Edition:
United States

Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

1.63CAD
6 Dec 2016
Change (% chg)

-- (--)
Prev Close
$1.63
Open
--
Day's High
--
Day's Low
--
Volume
30
Avg. Vol
13,443
52-wk High
$2.85
52-wk Low
$0.72

COV.V

Chart for COV.V

About

Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care, infection management and surgical procedures. The Company's wound care dressing products include ColActive Plus, ColActive Transfer, CovaWound Silicone, CovaWound Silicone Sacrum, CovaWound Foam, CovaWound... (more)
No analyst recommendations are available for COV.V.

Overall

Beta: 0.79
Market Cap(Mil.): $31.57
Shares Outstanding(Mil.): 19.37
Dividend: --
Yield (%): --

Financials

  COV.V Industry Sector
P/E (TTM): -- 55.81 30.77
EPS (TTM): -0.18 -- --
ROI: -29.77 7.05 15.23
ROE: -34.31 10.65 16.56

BRIEF-Covalon Technologies reports Q3 revenue c$2.6 million

* Q3 revenue c$2.6 million Source text for Eikon: Further company coverage:

Aug 19 2016

Earnings vs. Estimates

No consensus analysis data available.